• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    5.52 Up 0.04(0.73%) 4:00PM EDT
    Add to Portfolio
    Prev Close:5.48
    Open:5.37
    Bid:5.01 x 3000
    Ask:N/A
    1y Target Est:9.50
    Beta:2.2051
    Earnings Date:Nov 23 - Nov 27 (Est.)
    Day's Range:5.24 - 5.56
    52wk Range:4.35 - 17.42
    Volume:970,340
    Avg Vol (3m):1,073,360
    Market Cap:328.44M
    P/E (ttm):N/A
    EPS (ttm):-1.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARWRUp 0.73%328.44M
    PENCUp 5.14%15.59M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):853.56
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.58
    Quarterly EPS Est (Sep-15) :-0.39
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback